Sponsors List
We would like to thank our Sponsors and Exhibitors for their commitment & support and look forward to future collaborations.
Our Exhibitors welcome you at the exhibition area.
Status as of February 2025
ArtBio
Switzerland
Atonco Pharma
France
Capintec, a Mirion Medical company
USA
Capintec™, a Mirion Medical company, offers advanced nuclear medicine and molecular imaging instrumentation that enhances safety and efficiency. From dose preparation to patient administration and radiation protection, our products better the human condition by protecting people from exposure during potentially life-saving imaging and therapy.
CMR
Germany
CMR (Center of Molecular Research) was founded in 2001 by the group of professional scientists in nuclear medicine and international economic relations spheres firstly, focusing on production and distributing of Oxygen-18 water with Isotopic Enrichment ≥ 98% and other medicine isotopes. After more than 20 years of development today CMR is a vertically constructed united group of companies having its representatives and offices in many countries of the world. Nowadays CMR is not only one of the world's largest manufacturers of Oxygen-18 water but also the qualified supplier of a wide range of products including STABLE AND RADIOACTIVE ISOTOPES, PEPTIDES AND CHEMICAL KITS, which completely satisfy the needs of medicine centers and hospitals, scientists and technologists in nuclear medicine field.
GAIASO Theranostics
Australia
GAIASO Theranostics is an innovative company focused on transforming the diagnosis and treatment of female cancers through radioligand-based theranostics.
Emerging from a collaboration between Navigo Proteins GmbH and PreMIT Pty Ltd (an affiliate of the Melbourne Theranostic Innovation Centre), GAIASO unites a team of globally recognised experts. By leveraging cutting-edge platforms such as Affilin® protein engineering, GAIASO is developing a new generation of theranostic agents. These innovations harness the full potential of radiotherapy through deeper biological understanding of therapeutic targets, tunable biodistribution, and rational combination therapies designed to enhance radiation response.
Female cancers are often aggressive and progress to improve outcomes is urgently required. GAIASO’s team is determined to accelerate and deliver life-saving options for more women around the world.
GE HealthCare GmbH
France
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services and data analytics to make clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing connected and compassionate care, while simplifying the patient’s journey across the care pathway. Together, we’re creating a world where healthcare has no limits. Learn more at www.gehealthcare.com.
Hermes Medical Solutions SA
Sweden
ITM Isotope Technologies Munich SE
Germany
ITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including two phase III studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. By leveraging our nearly two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life.
LabLogic Systems Ltd
United Kingdom
Mediso Kft.
Hungary
MIM Software, a GE HealthCare Company
United States of America
MIM Software, a GE HealthCare Company, makes vendor-neutral imaging software to standardize workflows in Theranostics, Molecular Imaging, Radiation Oncology, and more. Leading global healthcare organizations use MIM to simplify increasingly complex clinical scenarios and give patients more precise, personalized care.
Seize opportunities and prepare for the future: MIM Theranostics solutions aim to make the promise of precision with Theranostics attainable. Practical solutions for patient selection, therapy response monitoring, dosimetry, and reporting can help clinics visualize the entire Theranostics pathway on a single, comprehensive software platform. Find out more at www.mimsoftware.com/solutions/theranostics.
Munich Precision Oncology GmbH
Germany
MPO’s objective is to develop and establish dedicated theranostic centers globally. The centers will provide the highest standard and cutting edge technology in theranostic patient care.
The pilot center will be located in the greater Munich area and will serve as a functional technology demonstrator in cooperation with leading clinical, academic and industrial partners.
Navigo Proteins
Germany
Navigo Proteins is a near-clinical biopharmaceutical company focused on Precision Medicine and next-generation radiotheranostics using its proprietary Affilin® platform. Affilins® are novel target-binding proteins, combining antibody and peptide advantages.
The growing Affilin® portfolio, supported by pre-clinical data, tackles key challenges in targeted therapeutics, achieving exceptional tumor-specific accumulation and favorable biodistribution. Industry collaborations with ITM, GAIASO Theranostics and additional in-house programs drive Affilin® development for radioligand therapy & imaging.
Navigo Proteins’ ultimate aim is to deliver best-in-class therapies and lifesaving products faster. The platform’s high modularity enables rapid innovation cycles using proven components.
For more information visit www.navigo-proteins.com and follow Navigo Proteins on LinkedIn.
Novartis
Switzerland
Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 108,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world.
© 2023 Novartis Pharma AG | CH-4002, Basel, Switzerland
Contact:
Address: Novartis Pharma AG, Forum 1, Novartis Campus, CH-4002, Basel, Switzerland
Tel: +41 61 324 11 11
Email: infomed@adacap.com
Social media:
Novartis (@Novartis) / Twitter
Novartis | LinkedIn
OncoBeta GmbH
Germany
PanTera
Belgium
SIEMENS Healthineers
Germany
SOFIE Biosciences
United States
SpectronRx Europe
Belgium
Telix Pharmaceuticals Limited
Switzerland
Telix is a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theragnostic’) radiopharmaceuticals.
Telix’s extensive pipeline for urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning is underpinned by a strong global supply, manufacturing, and distribution network.
Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the U.S. Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent and has more than 18 clinical trials underway worldwide.
Trasis
Belgium
At Trasis we are dedicated to helping the medical community access new radio-labelled therapeutic and diagnostic substances easily and faster.
To this end, we design, manufacture, sell and support high performance synthesizers (AllinOne, AllinOne mini, AllinOne S and EasyOne), Quality Control instrument (QC1) dose preparation equipment (Unidose), their shielding and accessories. We also develop customized synthetic methods and instruments. As certified GMP part I and Part II, we can supply active pharmaceutical ingredients (Api & Precursors) at the desired quality level and support our customers in their regulatory affairs.
Our proven radiopharmaceutical expertise, coupled with our high-end instruments, allow us to provide fully integrated solutions for an effective tracer production and faster transition from drug development to marketing authorization.
UNITED IMAGING HEALTHCARE EUROPE B.V.
The Netherlands
United Imaging Healthcare is dedicated to providing, developing and producing high-performance advanced medical imaging, radiotherapy equipment, life science instruments and offers intelligent digital solutions to customers worldwide. UIH is committed to creating more value for our customers and constantly improving the global accessibility of high-end medical equipment and services through in-depth cooperation with hospitals, universities, research institutions, and industry partners.
